# A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia

> **NCT07686679** · PHASE4 · RECRUITING · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** DA-9701
- **DRUG:** DA-9701-R
- **DRUG:** DA-9701 Placebo
- **DRUG:** DA-9701-R Placebo

## Key facts

- **NCT ID:** NCT07686679
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-06
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686679, "A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07686679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*